Skip to main content
SpringerPlus

Table 7 The most important side effects rated as strong by patients (VAS ≥50)

From: Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer – clinical evaluation of sensor-controlled scalp cooling

Side effect ≥50%

Patients with adjuvant CT (n = 58)

Patients with palliative CT (n = 6)

Feeling cold

22 (37.9%)

2 (33,3%)

Headache

14 (24.1%)

0

Heaviness of head

11 (18.9%)

0

Scalp pain

6 (10.3%)

1 (16,7%)

Back to article page